Ontology highlight
ABSTRACT:
SUBMITTER: Bai H
PROVIDER: S-EPMC7303762 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
BioMed research international 20200610
Multiple myeloma (MM) is a devastating cancer with a highly heterogeneous outcome. Because of the heterogeneity of myeloma cells, risk stratification is important for making therapeutic regimens. Nevertheless, no immunohistochemical predictive and prognostic marker has been constructed yet. In the present study, we explored the prognostic value of proteolipid protein 2 (PLP2) in MM patients using immunohistochemistry (IHC). We assessed PLP2 expression in bone marrow (BM) biopsy specimens obtaine ...[more]